Andrea Pfeifer
Vermögen: 9 Mio $ am 31.01.2026
Vermögen: 9 Mio $ am 31.01.2026
Andrea Pfeifer is the founder.
Dr. Pfeifer is the founder of AC Immune SA, serving as Chief Executive Officer since 2025.
Dr. Pfeifer is also the founder of Inventages II.
Current jobs include Chairman at BioMedInvest AG I, Chairman at AB2 Bio Ltd., Independent Member-Supervisory Board at Symrise AG since 2011, and Professor at the University of Lausanne.
Former jobs include Chairman at BioMedPartners AG, Member-Supervisory Board at 2invest AG, Principal at Nestlé USA, Inc., and Head-Global Research at Nestlé Nespresso SA. Education includes a doctorate from Wuerzburg Schweinfurt University of Applied Sciences, conferred in 1984.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AC IMMUNE SA 2,99 % | 01.03.2025 | 2.956.067 ( 2,99 % ) | 9 Mio $ | 31.01.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AC IMMUNE SA | Vorstandsvorsitzender | 13.02.2003 |
| SYMRISE AG | Direktor/Vorstandsmitglied | 01.05.2011 |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance Acts as Venture Capital Fund | Vorsitzender | - |
AB2 Bio SA
AB2 Bio SA Operates as a drug discovery and development company | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| 2INVEST AG | Direktor/Vorstandsmitglied | 18.10.2012 |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Designs and manufactures espresso machines | Corporate Officer/Principal | - |
Inventages II
Inventages II Investment ManagersFinance Acts as Venture Capital Fund | Gründer | - |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in early stage capital transactions. | Vorsitzender | - |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
2invest AG
2invest AG Financial ConglomeratesFinance Operates as an investment holding company primarily investing in biotechnology | Finance |
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Symrise AG
Symrise AG Chemicals: SpecialtyProcess Industries Produces fragrances and flavorings for taste, nutrition, health & scents | Process Industries |
Nestlé USA, Inc.
Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Manufactures and supplies baking, coffee, beverages, pet care, bottled water, frozen meals & infant nutrition products | Process Industries |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nestlé Nespresso SA
Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Designs and manufactures espresso machines | Producer Manufacturing |
Wuerzburg Schweinfurt University of Applied Sciences
Wuerzburg Schweinfurt University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in early stage capital transactions. | Finance |
Inventages II
Inventages II Investment ManagersFinance Acts as Venture Capital Fund | Finance |
AB2 Bio SA
AB2 Bio SA Operates as a drug discovery and development company |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition